SCHEMBL7148261

SCHEMBL7148261

COC1C(O)[C@@H](n2cnc3c(N)ncnc32)O[C@H]1CO

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 4/20 0.75
▸ ADORA1 P30542 3/20 0.75
▸ SMN1; SMN2 Q16637 2/20 0.75
▸ PI4KA P42356 2/20 0.75
▸ PI4K2B Q8TCG2 2/20 0.75
▸ PI4K2A Q9BTU6 2/20 0.75
▸ PI4KB Q9UBF8 2/20 0.75
▸ DPP4 P27487 1/20 0.75
▸ MEN1 O00255 1/20 0.75
▸ SLC28A1 O00337 1/20 0.75
▸ MAP3K7 O43318 1/20 0.75
▸ SLC28A2 O43868 1/20 0.75
▸ GAPDH P04406 1/20 0.75
▸ MAPK1 P28482 1/20 0.75
▸ ADORA2A P29274 1/20 0.75
▸ ADORA2B P29275 1/20 0.75
▸ STAT6 P42226 1/20 0.75
▸ KMT2A Q03164 1/20 0.75
▸ DOT1L Q8TEK3 1/20 0.75
▸ SLC29A1 Q99808 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21418864 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL29748808 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL17972355 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL3369124 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL1066939 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL23547979 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL16359953 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL16724749 1.00 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL25936 0.91 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B
SCHEMBL24538798 0.91 ADORA3 (0.75) ADORA3ADORA1SMN1; SMN2PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605713-B1 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability FURSTE JENS PETER (DE) 2003-08-12 — — US disclosed
EP-0934331-B1 MIRROR-SYMMETRICAL SELECTION AND EVOLUTION OF NUCLEIC ACIDS FUERSTE JENS PETER (DE) 2002-11-27 — — EP disclosed
EP-0934331-A2 MIRROR-SYMMETRICAL SELECTION AND EVOLUTION OF NUCLEIC ACIDS Fürste, Jens Peter (DE) 1999-08-11 — — EP disclosed
WO-1998008856-A2 MIRROR-SYMMETRICAL SELECTION AND EVOLUTION OF NUCLEIC ACIDS FUERSTE JENS PETER (DE) 1998-03-05 — — WO disclosed
Send feedback